Please Wait
Applying Filters...
menu
    • menu
    LGM Pharma-PSE
    News
    N-Zyme & LGM Pharma Create Novel Pepsin Inhibitor Therapy

    18 Nov 2024

    // PRESS RELEASE

    New Harbor Capital Portfolio Company LGM Pharma Promotes CFO& CCO

    22 Oct 2024

    // PRESS RELEASE

    LGM Pharma Expands Its Analytical Testing Services

    15 Oct 2024

    // PRESS RELEASE

    Data Compilation
    #PharmaFlow

    LGM Pharma RMU

    Contact Supplier

    Website

    AES 2024

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    speak-pharma/lgm-pharma-has-made-significant-strides-in-meeting-the-evolving-needs-of-its-clients
    Menu

    LGM Pharma

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    Key Products KEY PRODUCTS

    SERVICES

    Key Services KEY SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital content

    Explore the latest content creation from this company

    INTERVIEW #SpeakPharma

    read-more
    read-more
    “LGM Pharma has made significant strides in meeting the evolving needs of its clients”

    “LGM Pharma has made significant strides in meeting the evolving needs of its clients”

    This week, SpeakPharma interviews four senior executives of LGM Pharma — Shailesh Vengurlekar (Senior VP, Quality and Regulatory Affairs), Deepak Thassu (Senior VP, R&D and Regulatory Submission), Selwyn Lustman (Senior VP, Global Sourcing and Procurement), and Mike Stenberg (VP, Business Development). The four VPs talk about expansion in manufacturing capabilities of the Florida-based contract development and manufacturing organization (CDMO), expertise that makes LGM a strong partner and the criteria it adopts while selecting its suppliers.  HIGHLIGHTS// expansion in manufacturing capabilities/ expertise that makes LGM a strong partner/ criteria for selecting its suppliers LGM Pharma recently invested heavily in expanding its CDMO capabilities by 50 percent. Can you share why offering standalone analytical testing services is important to LGM Pharma’s growth strategy? How does it benefit your clients? Vengurlekar: This recent expansion in CDMO capabilities is part of LGM Pharma’s growth strategy that lays importance on diversification. One key area of this diversification is the offering of standalone Analytical Testing Services (ATS). This service plays a crucial role in supporting our clients by providing them with greater flexibility and reliability. LGM Pharma is already a well-established leader in the API supply chain. We have now identified a significant need in the market and are now serving compounding pharmacies, including 503A and 503B facilities. These pharmacies not only require high-quality, GMP-compliant APIs, but also need a trusted, compliant, and capable laboratory to analyze both their APIs and compounded products. Recognizing this opportunity to further support our clients, LGM Pharma has expanded into ATS. We have witnessed tremendous growth since we’ve launched these services. By offering ATS under a separate legal entity — LGM Pharma Solutions — we are able to provide an additional layer of flexibility to our clients. This structure eliminates any conflict of interest. While LGM Pharma LLC handles API supply, LGM Pharma Solutions focuses on delivering top-tier ATS, all under the same LGM Pharma umbrella. This setup enhances trust and allows our clients to work with us more seamlessly. HIGHLIGHTS// diversified into standalone ATS/ well-established leader in API supply chain/ serving compounding pharmacies/ offering APIs and ATS under different legal entities. While suppositories offer clear advantages for certain medications, can you describe how LGM Pharma plans to leverage its expertise in this area to address specific unmet needs in the growing women’s health market? Thassu: We’re taking a dual approach to enhance both our R&D and manufacturing capabilities. First, we’ve introduced a new semi-automatic machine that allows us to produce smaller batches more efficiently. This is particularly important for the suppository segment, where demand doesn’t require large-scale production. The new system enables quicker adjustments to the manufacturing process, providing us with greater flexibility of producing small batches. Second, many of the materials we handle in the women’s health sector are sensitive to heat, light, and oxygen. To address this, we’re upgrading our facility to accommodate these specialized requirements. This ensures we can develop and manufacture products while maintaining the integrity of heat-, light-, and oxygen-sensitive ingredients. Additionally, we’re working closely with clients to prepare for various technical challenges. Whether it’s processing homeopathic ingredients or handling delicate fermentation-based materials, which are highly sensitive to both light and heat, our team has upgraded its skills and equipment to manage these complexities. From technology advancements in manufacturing to specialized handling conditions and improved technical expertise, we’ve made significant strides to ensure we can meet the evolving needs of our clients and their products. HIGHLIGHTS// dual approach to enhance R&D and manufacturing capabilities/ upgrading facilities to accommodate specialized requirements/ working with clients to address challenges. The pandemic underscored supply chain problems. Can you detail the specific criteria LGM Pharma uses while selecting suppliers for its manufacturing processes? Lustman: LGM looks at many facets of a manufacturer before proceeding to approve them for a specific project. We start by checking their regulatory history with the US Food and Drug Administration (FDA) and other authorities. We try to find out if they have received any warning letters. What is their inspection history? Have they received NAIs (no action indicated) and VAIs (voluntary action indicated)? We further investigate the company’s overall business status — we need to know that they are a stable partner to work with in the long term. Manufacturers are then assessed for their overall technology and the number of employees working in various fields, such as R&D, quality control, quality assurance, regulatory affairs, manufacturing, and the educational levels of these employees. Once we have established that the manufacturer is a potential partner, we check their status for a particular project. We look at their advantages, and whether they have a non-infringing route of synthesis (ROS) that will allow early launch. Are they developing a second process that will be more competitive in pricing? And, does the manufacturer have the necessary capacity and/or spare capacity for the project that we are assessing? We need to know whether the drug master file (DMF) has been registered, the current batch size, and the potential for increase in batch size. Pricing is a key indicator — we need to know whether the pricing of the manufacturer is competitive or not, and if the manufacturer will be able to compete in the future as the project matures. LGM always assesses for quality, price, and delivery. Goods must be of the correct quality, at the right price, with delivery time as desired, in order to meet commercial needs. HIGHLIGHTS// investigate various facets of manufacturer before approving them for a project/ look at advantages, non-infringing ROS/ assess for quality, price, delivery Can you highlight specific capabilities and experiences LGM Pharma possesses that make it a strong partner for companies developing antibody-drug-conjugates (ADCs)? Stenberg: ADCs are often peptides linked with small molecules. However, they may also be peptides linked with oligonucleotides. Regardless, LGM can help manage the supply chain associated with the components that are used in the conjugation of the ADC. LGM has extensive experience, and an extensive network around sourcing and managing the supply chain associated with ADC components. LGM’s experience and capabilities extend to sourcing peptides, small molecules or oligonucleotides used in the conjugation process. Additionally, given our deep relationships in the supply chain aspect of this process, LGM may also be able to identify partners who can help with the conjugation process itself. HIGHLIGHTS// extensive experience, network around sourcing, managing supply chain associated with ADC components / identify partners that can help with conjugation process

    Impressions: 1267

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/lgm-pharma-has-made-significant-strides-in-meeting-the-evolving-needs-of-its-clients

    #SpeakPharma With LGM Pharma
    09 Nov 2024
    Share info Share

    CORPORATE CONTENT #SupplierSpotlight

    Product List 2023

    read-more

      https://www.pharmacompass.com/pdf/party/content/lgm-pharma-party-content-60991.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Corporate Presentation

    read-more

      https://www.pharmacompass.com/pdf/party/content/lgm-pharma-party-content-13141.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Five Reasons to Outsource API Procurement

    read-more

      https://www.pharmacompass.com/pdf/party/content/lgm-pharma-party-content-44567.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    DATA COMPILATION #PharmaFlow

    read-more
    read-more
    CDMO Activity Tracker: Novo’s parent buys Catalent for US$ 16.5 bn; Fujifilm, Merck KGaA, Axplora expand capabilities

    CDMO Activity Tracker: Novo’s parent buys Catalent for US$ 16.5 bn; Fujifilm, Merck KGaA, Axplora expand capabilities

    During the first half (H1) of 2024, the global contract development and manufacturing organization (CDMO) landscape was driven by the escalating demand for complex drug development and manufacturing.With the industry grappling with constantly evolving therapeutic modalities, CDMOs are racing to invest in cutting-edge technologies and infrastructure to meet the growing needs of pharmaceutical and biotech companies.Some of the key players in the CDMO space are Catalent, EUROAPI, Lonza, Axplora, Thermo Fisher, SEQENS, Samsung Biologics, Fujifilm Diosynth Biotechnologies, Quotient Sciences, Famar, LGM Pharma, Veranova, and Evonik. View CDMO Activity Tracker for H1 2024 (Free Excel Available)Novo’s parent buys Catalent for US$ 16.5 bn; Bora, Lonza, Siegfried expand US footprintDuring H1 2024, several European and Asian drugmakers expanded their footprints in the US. In February, Novo Nordisk’s parent company, the Novo Nordisk Foundation, announced the acquisition of Catalent through its investment arm Novo Holdings for US$ 16.5 billion. Novo Holdings plans to sell three of Catalent’s “fill-finish” sites to Novo Nordisk for US$ 11 billion. The deal is expected to allow the Danish drugmaker “to serve significantly more people living with diabetes and obesity,” a company statement said.Taiwan-headquartered Bora Pharmaceuticals forged ahead with its expansion plans in the US market by acquiring Minnesota-based generics manufacturer Upsher-Smith Laboratories. Emergent BioSolutions said it is selling its Maryland facility to an affiliate of Bora. This site in Camden is part of its CDMO, Emergent Bioservices, and offers clinical and commercial non-viral aseptic fill/finish services on four fill lines, including lyophilization, formulation development, and support services.Swiss drugmaker Lonza has agreed to acquire Genentech’s manufacturing facility in California, US, from Roche for US$ 1.2 billion in cash. The site, located in the city of Vacaville, is one of the largest biologics manufacturing facilities in the world by volume.Lonza also launched an artificial intelligence-driven route design technology for choosing the optimal synthetic pathway to manufacture novel APIs.Switzerland’s Siegfried is acquiring a Wisconsin (US)-based CDMO that specializes in early-phase development and manufacturing services from Curia Global to strengthen its capabilities in North America. Siegfried will further develop the site into its North American Siegfried Acceleration Hub for early-phase CDMO services. View CDMO Activity Tracker for H1 2024 (Free Excel Available) Merck Millipore, SK Bioscience lead CGT boom; Fujifilm, Axplora, expand CDMO capabilitiesThe burgeoning field of cell and gene therapies (CGTs) is driving significant investments in CDMOs. CGTs saw considerable deal-making too. Merck KGaA agreed to buy Wisconsin-based Mirus Bio for US$ 600 million. Mirus Bio is a specialist in the development and commercialization of transfection reagents that are used to help introduce genetic material into cells. These reagents play a key role in the production of viral vectors for CGTs.Similarly, South Korea’s SK Bioscience acquired a 60 percent stake in IDT Biologika GmbH for KRW 339 billion (US$ 244 million). IDT Biologika is a 104-year-old German company that ranks among the top 10 vaccine producers in the world.CDMOs are also expanding their capabilities in order to lead innovation for their pharmaceutical partners. Fujifilm Diosynth Biotechnologies is investing US$ 1.2 billion in its large-scale cell culture CDMO business to further expand its end-to-end bio-manufacturing facility in North Carolina, bringing the total investment in the facility to over US$ 3.2 billion. Similarly, Merck KGaA owned MilliporeSigma made its biggest investment in the Asia-Pacific region in March when it invested € 300 million (US$ 327 million) in a new bioprocessing production center in Daejeon, South Korea.German CDMO giant Axplora is investing € 8 million (US$ 8.73 million) to expand capacity for antibody drug conjugate (ADC) payload manufacturing at its Le Mans site in France. Catalent completed upgrades to its capsule filling capabilities of dry powders for inhalation to handle potent drugs at its Boston facility. This now positions Catalent as the CDMO with the largest GMP capacity for capsule spray-dried and carrier-based inhaled powders.LGM Pharma increased its Analytical Testing Services (ATS) by 50 percent with a US$ 2 million investment and introduced new suppository manufacturing capabilities to its CDMO portfolio. Minakem has invested in a new production unit in Montreal, Canada, for steroid APIs. View CDMO Activity Tracker for H1 2024 (Free Excel Available) EUROAPI kicks off four-year sweeping plan; LegoChem partners Samsung Biologics for ADC programSanofi’s spinoff EUROAPI marked 2024 as a “transition year”, setting in motion its Focus-27 plan for profitable growth in the future. The sweeping four-year plan includes a streamlined value-added portfolio focused on highly differentiated and profitable APIs, and a CDMO focused on late-stage and high-value complex small molecules and tides supported by unique technological platforms. The leading French small molecules player signed a five-year collaboration with Ireland’s Priothera wherein EUROAPI will develop and industrialize the manufacturing process of an innovative, complex molecule for blood cancers – mocravimod. The project will be carried out at EUROAPI’s site in Budapest, which is its center of excellence for complex chemistry.South Korea’s CDMO powerhouse Samsung Biologics has partnered LegoChem Biosciences and will provide antibody development and drug substance manufacturing services as a part of LegoChem’s ADC program designed to treat solid tumors. LegoChem aims to submit an investigational new drug application to the US Food and Drug Administration (FDA) in the first half of 2025. Aurigene and Vipergen have joined forces to offer DNA-encoded library (DEL) screening for drug discovery. By combining Aurigene’s drug discovery capabilities with Vipergen’s DEL screening technologies, they seek to create a powerful tool that can quickly test over a billion small-molecule compounds against different disease targets. Dr. Reddy’s Laboratories’ company Aurigene also inaugurated its biologics facility spread across 70,000 square feet.Chinese biotech startup Pleryon is collaborating with France’s SEQENS, a leader in specialty ingredients, to develop and manufacture the former’s lead candidate, an innovative polymer to treat osteoarthritis. Famar is collaborating with Lavipharm and will serve as the contract manufacturer for the latter’s recently added analgesic pharmaceutical products — Lonarid N and Lonalgal. View CDMO Activity Tracker for H1 2024 (Free Excel Available) Our view Key trends observed in H1 2024 include a surge in investments for fill-finish facilities, a growing emphasis on cell and gene therapies, and advancements in ADC manufacturing. With the proliferation of these new classes of drugs, the CDMO space has been rapidly changing in recent years. In the future, the integration of digital technologies, such as AI and automation, will be a key differentiator for CDMOs looking to optimize their operations and accelerate drug development timelines. 
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 2989

    https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-novo-s-parent-buys-catalent-for-us-16-5-bn-fujifilm-merck-kgaa-axplora-lonza-expand-capabilities

    #PharmaFlow by PHARMACOMPASS
    08 Aug 2024
    Share Share

    NEWS #PharmaBuzz

    read-more
    read-more
    N-Zyme & LGM Pharma Create Novel Pepsin Inhibitor Therapy
    N-Zyme & LGM Pharma Create Novel Pepsin Inhibitor Therapy

    18 Nov 2024

    // PRESS RELEASE

    https://lgmpharma.com/blog/n-zyme-biomedical-and-lgm-pharma-are-developing-the-worlds-first-pepsin-inhibitor-for-reflux-disease/

    PRESS RELEASE
    18 Nov 2024
    Share Share
    New Harbor Capital Portfolio Company LGM Pharma Promotes CFO& CCO
    New Harbor Capital Portfolio Company LGM Pharma Promotes CFO& CCO

    22 Oct 2024

    // PRESS RELEASE

    https://lgmpharma.com/blog/new-harbor-capital-portfolio-company-lgm-pharma-promotes-cfo-and-cco/

    PRESS RELEASE
    22 Oct 2024
    Share Share
    LGM Pharma Expands Its Analytical Testing Services
    LGM Pharma Expands Its Analytical Testing Services

    15 Oct 2024

    // PRESS RELEASE

    https://lgmpharma.com/blog/lgm-pharma-expands-analytical-testing-services-with-new-endotoxin-and-rapid-sterility-testing-capabilities/

    PRESS RELEASE
    15 Oct 2024
    Share Share
    New Harbor Compleate Recapitalizes LGM For Strategic Growth
    New Harbor Compleate Recapitalizes LGM For Strategic Growth

    01 Oct 2024

    // PRESS RELEASE

    https://lgmpharma.com/blog/new-harbor-capital-completes-recapitalization-of-portfolio-company-lgm-pharma-to-support-its-continued-growth/

    PRESS RELEASE
    01 Oct 2024
    Share Share
    LGM Pharma Unveils Enhanced Analytical Testing Services & Expands CDMO Portfolio
    LGM Pharma Unveils Enhanced Analytical Testing Services & Expands CDMO Portfolio

    22 Mar 2024

    // PRESS RELEASE

    https://lgmpharma.com/blog/lgm-pharma-unveils-enhanced-analytical-testing-services-and-expands-cdmo-portfolio-with-additional-suppository-manufacturing-capabilities/

    PRESS RELEASE
    22 Mar 2024
    Share Share
    LGM Pharma Boosts Capabilities with Investment in Analytical Testing & Suppository Manufacturing in Rosenburg, Texas
    LGM Pharma Boosts Capabilities with Investment in Analytical Testing & Suppository Manufacturing in Rosenburg, Texas

    13 Mar 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240313734946/en/LGM-Pharma-Unveils-Enhanced-Analytical-Testing-Services-and-Expands-CDMO-Portfolio-with-Additional-Suppository-Manufacturing-Capabilities

    BUSINESSWIRE
    13 Mar 2024
    Share Share
    Contact Lgm Pharma and get a quotation

    Lgm Pharma is a supplier offers 583 products (APIs, Excipients or Intermediates).

    Find a price of Abacavir Sulfate bulk offered by Lgm Pharma

    Find a price of Abiraterone Acetate bulk offered by Lgm Pharma

    Find a price of Acamprosate Calcium bulk offered by Lgm Pharma

    Find a price of Aceclofenac bulk offered by Lgm Pharma

    Find a price of Acetazolamide bulk offered by Lgm Pharma

    Find a price of Aciclovir bulk offered by Lgm Pharma

    Find a price of Adalimumab bulk offered by Lgm Pharma

    Find a price of Adapalene bulk offered by Lgm Pharma

    Find a price of Afatinib bulk offered by Lgm Pharma

    Find a price of Agomelatine bulk offered by Lgm Pharma

    Find a price of Albendazole bulk offered by Lgm Pharma

    Find a price of Alemtuzumab bulk offered by Lgm Pharma

    Find a price of Alendronate Sodium bulk offered by Lgm Pharma

    Find a price of Alfacalcidol bulk offered by Lgm Pharma

    Find a price of Alfuzosin HCl bulk offered by Lgm Pharma

    Find a price of Alirocumab bulk offered by Lgm Pharma

    Find a price of Allopurinol bulk offered by Lgm Pharma

    Find a price of Alogliptin Benzoate bulk offered by Lgm Pharma

    Find a price of Alpha Lipoic Acid bulk offered by Lgm Pharma

    Find a price of Alprazolam bulk offered by Lgm Pharma

    Find a price of Alprostadil bulk offered by Lgm Pharma

    Find a price of Amantadine Hydrochloride bulk offered by Lgm Pharma

    Find a price of Ambrisentan bulk offered by Lgm Pharma

    Find a price of Ambroxol Hydrochloride bulk offered by Lgm Pharma

    Find a price of Aminocaproic Acid bulk offered by Lgm Pharma

    Find a price of Amisulpride bulk offered by Lgm Pharma

    Find a price of Amitriptyline Hydrochloride bulk offered by Lgm Pharma

    Find a price of Amlodipine Besylate bulk offered by Lgm Pharma

    Find a price of Amorolfine Hydrochloride bulk offered by Lgm Pharma

    Find a price of Amoxicillin Trihydrate bulk offered by Lgm Pharma

    Find a price of Amphotericin B bulk offered by Lgm Pharma

    Find a price of Ampicillin Sodium bulk offered by Lgm Pharma

    Find a price of Anastrozole bulk offered by Lgm Pharma

    Find a price of Anidulafungin bulk offered by Lgm Pharma

    Find a price of Apixaban bulk offered by Lgm Pharma

    Find a price of Aprepitant bulk offered by Lgm Pharma

    Find a price of Aripiprazole bulk offered by Lgm Pharma

    Find a price of Asenapine Maleate bulk offered by Lgm Pharma

    Find a price of Atazanavir Sulfate bulk offered by Lgm Pharma

    Find a price of Atenolol bulk offered by Lgm Pharma

    Find a price of Atezolizumab bulk offered by Lgm Pharma

    Find a price of Atomoxetin Hydrochloride bulk offered by Lgm Pharma

    Find a price of Atorvastatin bulk offered by Lgm Pharma

    Find a price of Atosiban bulk offered by Lgm Pharma

    Find a price of Atovaquone bulk offered by Lgm Pharma

    Find a price of Atracurium Besylate bulk offered by Lgm Pharma

    Find a price of Atropine Sulfate bulk offered by Lgm Pharma

    Find a price of Avanafil bulk offered by Lgm Pharma

    Find a price of Axitinib bulk offered by Lgm Pharma

    Find a price of Azacitidine bulk offered by Lgm Pharma

    Find a price of Azathioprine bulk offered by Lgm Pharma

    Find a price of Azelastine Hydrochloride bulk offered by Lgm Pharma

    Find a price of Azilsartan bulk offered by Lgm Pharma

    Find a price of Azithromycin Dihydrate bulk offered by Lgm Pharma

    Find a price of Baclofen bulk offered by Lgm Pharma

    Find a price of Baricitinib bulk offered by Lgm Pharma

    Find a price of Bazedoxifene Acetate bulk offered by Lgm Pharma

    Find a price of Beclomethasone Dipropionate bulk offered by Lgm Pharma

    Find a price of Bendamustine Hydrochloride bulk offered by Lgm Pharma

    Find a price of Benzocaine bulk offered by Lgm Pharma

    Find a price of Beta Nicotinamide Adenine Dinucleotide bulk offered by Lgm Pharma

    Find a price of Betahistine Dihydrochloride bulk offered by Lgm Pharma

    Find a price of Betamethasone bulk offered by Lgm Pharma

    Find a price of Bevacizumab bulk offered by Lgm Pharma

    Find a price of Bicalutamide bulk offered by Lgm Pharma

    Find a price of Bilastine bulk offered by Lgm Pharma

    Find a price of Bimatoprost bulk offered by Lgm Pharma

    Find a price of Bisacodyl bulk offered by Lgm Pharma

    Find a price of Bivalirudin bulk offered by Lgm Pharma

    Find a price of Bortezomib bulk offered by Lgm Pharma

    Find a price of Bosentan Hydrate bulk offered by Lgm Pharma

    Find a price of Brexpiprazole bulk offered by Lgm Pharma

    Find a price of Brimonidine Tartrate bulk offered by Lgm Pharma

    Find a price of Brinzolamide bulk offered by Lgm Pharma

    Find a price of Brivaracetam bulk offered by Lgm Pharma

    Find a price of Bromfenac Sodium bulk offered by Lgm Pharma

    Find a price of Bromhexine Hydrochloride bulk offered by Lgm Pharma

    Find a price of Budesonide bulk offered by Lgm Pharma

    Find a price of Bupivacaine bulk offered by Lgm Pharma

    Find a price of Buprenorphine bulk offered by Lgm Pharma

    Find a price of Bupropion Hydrobromide bulk offered by Lgm Pharma

    Find a price of Bupropion Hydrochloride bulk offered by Lgm Pharma

    Find a price of Busulfan bulk offered by Lgm Pharma

    Find a price of Cabazitaxel bulk offered by Lgm Pharma

    Find a price of Cabergoline bulk offered by Lgm Pharma

    Find a price of Cabozantinib bulk offered by Lgm Pharma

    Find a price of Calcipotriol bulk offered by Lgm Pharma

    Find a price of Calcitriol bulk offered by Lgm Pharma

    Find a price of Canagliflozin bulk offered by Lgm Pharma

    Find a price of Candesartan Cilexetil bulk offered by Lgm Pharma

    Find a price of Capecitabine bulk offered by Lgm Pharma

    Find a price of Captopril bulk offered by Lgm Pharma

    Find a price of Carbamazepine bulk offered by Lgm Pharma

    Find a price of Carbidopa bulk offered by Lgm Pharma

    Find a price of Carboplatin bulk offered by Lgm Pharma

    Find a price of Carboprost Tromethamine bulk offered by Lgm Pharma

    Find a price of Carfilzomib bulk offered by Lgm Pharma

    Find a price of Carmustine bulk offered by Lgm Pharma

    Find a price of Caspofungin bulk offered by Lgm Pharma

    Find a price of Cefdinir bulk offered by Lgm Pharma

    Find a price of Cefpodoxime Proxetil bulk offered by Lgm Pharma

    Find a price of Cefuroxime Axetil bulk offered by Lgm Pharma

    Find a price of Celecoxib bulk offered by Lgm Pharma

    Find a price of Cetirizine Dihydrochloride bulk offered by Lgm Pharma

    Find a price of Cetrorelix Acetate bulk offered by Lgm Pharma

    Find a price of Chloramphenicol Succinate Acid bulk offered by Lgm Pharma

    Find a price of Chloroquine Phosphate bulk offered by Lgm Pharma

    Find a price of Chlorpheniramine Maleate bulk offered by Lgm Pharma

    Find a price of Chlorpromazine Hydrochloride bulk offered by Lgm Pharma

    Find a price of Cilostazol bulk offered by Lgm Pharma

    Find a price of Cinnarizine bulk offered by Lgm Pharma

    Find a price of Ciprofloxacin bulk offered by Lgm Pharma

    Find a price of Ciprofloxacin Hydrochloride bulk offered by Lgm Pharma

    Find a price of Cisatracurium Besylate bulk offered by Lgm Pharma

    Find a price of Cisplatin bulk offered by Lgm Pharma

    Find a price of Citalopram Hydrobromide bulk offered by Lgm Pharma

    Find a price of Citicoline Sodium bulk offered by Lgm Pharma

    Find a price of Clarithromycin bulk offered by Lgm Pharma

    Find a price of Clenbuterol Hydrochloride bulk offered by Lgm Pharma

    Find a price of Clindamycin Phosphate bulk offered by Lgm Pharma

    Find a price of Clobetasol Propionate bulk offered by Lgm Pharma

    Find a price of Clofarabine bulk offered by Lgm Pharma

    Find a price of Clomipramine Hydrochloride bulk offered by Lgm Pharma

    Find a price of Clonazepam bulk offered by Lgm Pharma

    Find a price of Clonidine bulk offered by Lgm Pharma

    Find a price of Clopidogrel bulk offered by Lgm Pharma

    Find a price of Cloprostenol Sodium bulk offered by Lgm Pharma

    Find a price of Clostebol Acetate bulk offered by Lgm Pharma

    Find a price of Clotrimazole bulk offered by Lgm Pharma

    Find